Global Albendazole Veterinary Drug Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 114
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Capsule Product

- Table Product

Segment by Application

- Swine

- Cattle

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- GSK

- Sequent Scientific

- Zoetis

- AdvaCare Pharma

- Guangdong Tianbao Biological Pharmaceutical Co., Ltd.

- Hanzhonghe Times Biotechnology Co., Ltd.

- Yahui Medicine

- Beijing Shengmu Biotechnology Co., Ltd.

- Hebei Huabang Biological Technology Co., Ltd.

- Dongguan Meidehao Animal Pharmaceutical Co., Ltd.

- Sichuan Jinfeng Technology

- Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd.

- Anhui Shenhui Agricultural Technology Co., Ltd.

- Foshan Zhengdian Biotechnology Co., Ltd.

- Shanghai Shenya

- Tianjin Bijia Pharmaceutical Co., Ltd.

- Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province

- Shimu Group

- CSTP

- Sneha Medicare

Global Albendazole Veterinary Drug Market Research Report 2022

Table of Contents
1 Albendazole Veterinary Drug Market Overview
1.1 Product Overview and Scope of Albendazole Veterinary Drug
1.2 Albendazole Veterinary Drug Segment by Type
1.2.1 Global Albendazole Veterinary Drug Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Capsule Product
1.2.3 Table Product
1.3 Albendazole Veterinary Drug Segment by Application
1.3.1 Global Albendazole Veterinary Drug Sales Comparison by Application: (2022-2028)
1.3.2 Swine
1.3.3 Cattle
1.3.4 Others
1.4 Global Albendazole Veterinary Drug Market Size Estimates and Forecasts
1.4.1 Global Albendazole Veterinary Drug Revenue 2017-2028
1.4.2 Global Albendazole Veterinary Drug Sales 2017-2028
1.4.3 Albendazole Veterinary Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Albendazole Veterinary Drug Market Competition by Manufacturers
2.1 Global Albendazole Veterinary Drug Sales Market Share by Manufacturers (2017-2022)
2.2 Global Albendazole Veterinary Drug Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Albendazole Veterinary Drug Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Albendazole Veterinary Drug Manufacturing Sites, Area Served, Product Type
2.5 Albendazole Veterinary Drug Market Competitive Situation and Trends
2.5.1 Albendazole Veterinary Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Albendazole Veterinary Drug Players Market Share by Revenue
2.5.3 Global Albendazole Veterinary Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Albendazole Veterinary Drug Retrospective Market Scenario by Region
3.1 Global Albendazole Veterinary Drug Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Albendazole Veterinary Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Albendazole Veterinary Drug Market Facts & Figures by Country
3.3.1 North America Albendazole Veterinary Drug Sales by Country
3.3.2 North America Albendazole Veterinary Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Albendazole Veterinary Drug Market Facts & Figures by Country
3.4.1 Europe Albendazole Veterinary Drug Sales by Country
3.4.2 Europe Albendazole Veterinary Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Albendazole Veterinary Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Albendazole Veterinary Drug Sales by Region
3.5.2 Asia Pacific Albendazole Veterinary Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Albendazole Veterinary Drug Market Facts & Figures by Country
3.6.1 Latin America Albendazole Veterinary Drug Sales by Country
3.6.2 Latin America Albendazole Veterinary Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Albendazole Veterinary Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Albendazole Veterinary Drug Sales by Country
3.7.2 Middle East and Africa Albendazole Veterinary Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Albendazole Veterinary Drug Historic Market Analysis by Type
4.1 Global Albendazole Veterinary Drug Sales Market Share by Type (2017-2022)
4.2 Global Albendazole Veterinary Drug Revenue Market Share by Type (2017-2022)
4.3 Global Albendazole Veterinary Drug Price by Type (2017-2022)
5 Global Albendazole Veterinary Drug Historic Market Analysis by Application
5.1 Global Albendazole Veterinary Drug Sales Market Share by Application (2017-2022)
5.2 Global Albendazole Veterinary Drug Revenue Market Share by Application (2017-2022)
5.3 Global Albendazole Veterinary Drug Price by Application (2017-2022)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.1.4 GSK Albendazole Veterinary Drug Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sequent Scientific
6.2.1 Sequent Scientific Corporation Information
6.2.2 Sequent Scientific Description and Business Overview
6.2.3 Sequent Scientific Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Sequent Scientific Albendazole Veterinary Drug Product Portfolio
6.2.5 Sequent Scientific Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Corporation Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Zoetis Albendazole Veterinary Drug Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 AdvaCare Pharma
6.4.1 AdvaCare Pharma Corporation Information
6.4.2 AdvaCare Pharma Description and Business Overview
6.4.3 AdvaCare Pharma Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AdvaCare Pharma Albendazole Veterinary Drug Product Portfolio
6.4.5 AdvaCare Pharma Recent Developments/Updates
6.5 Guangdong Tianbao Biological Pharmaceutical Co., Ltd.
6.5.1 Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Corporation Information
6.5.2 Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Product Portfolio
6.5.5 Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Hanzhonghe Times Biotechnology Co., Ltd.
6.6.1 Hanzhonghe Times Biotechnology Co., Ltd. Corporation Information
6.6.2 Hanzhonghe Times Biotechnology Co., Ltd. Description and Business Overview
6.6.3 Hanzhonghe Times Biotechnology Co., Ltd. Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Hanzhonghe Times Biotechnology Co., Ltd. Albendazole Veterinary Drug Product Portfolio
6.6.5 Hanzhonghe Times Biotechnology Co., Ltd. Recent Developments/Updates
6.7 Yahui Medicine
6.6.1 Yahui Medicine Corporation Information
6.6.2 Yahui Medicine Description and Business Overview
6.6.3 Yahui Medicine Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Yahui Medicine Albendazole Veterinary Drug Product Portfolio
6.7.5 Yahui Medicine Recent Developments/Updates
6.8 Beijing Shengmu Biotechnology Co., Ltd.
6.8.1 Beijing Shengmu Biotechnology Co., Ltd. Corporation Information
6.8.2 Beijing Shengmu Biotechnology Co., Ltd. Description and Business Overview
6.8.3 Beijing Shengmu Biotechnology Co., Ltd. Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Beijing Shengmu Biotechnology Co., Ltd. Albendazole Veterinary Drug Product Portfolio
6.8.5 Beijing Shengmu Biotechnology Co., Ltd. Recent Developments/Updates
6.9 Hebei Huabang Biological Technology Co., Ltd.
6.9.1 Hebei Huabang Biological Technology Co., Ltd. Corporation Information
6.9.2 Hebei Huabang Biological Technology Co., Ltd. Description and Business Overview
6.9.3 Hebei Huabang Biological Technology Co., Ltd. Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Hebei Huabang Biological Technology Co., Ltd. Albendazole Veterinary Drug Product Portfolio
6.9.5 Hebei Huabang Biological Technology Co., Ltd. Recent Developments/Updates
6.10 Dongguan Meidehao Animal Pharmaceutical Co., Ltd.
6.10.1 Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Corporation Information
6.10.2 Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Product Portfolio
6.10.5 Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Sichuan Jinfeng Technology
6.11.1 Sichuan Jinfeng Technology Corporation Information
6.11.2 Sichuan Jinfeng Technology Albendazole Veterinary Drug Description and Business Overview
6.11.3 Sichuan Jinfeng Technology Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Sichuan Jinfeng Technology Albendazole Veterinary Drug Product Portfolio
6.11.5 Sichuan Jinfeng Technology Recent Developments/Updates
6.12 Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd.
6.12.1 Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Corporation Information
6.12.2 Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Description and Business Overview
6.12.3 Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Product Portfolio
6.12.5 Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Anhui Shenhui Agricultural Technology Co., Ltd.
6.13.1 Anhui Shenhui Agricultural Technology Co., Ltd. Corporation Information
6.13.2 Anhui Shenhui Agricultural Technology Co., Ltd. Albendazole Veterinary Drug Description and Business Overview
6.13.3 Anhui Shenhui Agricultural Technology Co., Ltd. Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Anhui Shenhui Agricultural Technology Co., Ltd. Albendazole Veterinary Drug Product Portfolio
6.13.5 Anhui Shenhui Agricultural Technology Co., Ltd. Recent Developments/Updates
6.14 Foshan Zhengdian Biotechnology Co., Ltd.
6.14.1 Foshan Zhengdian Biotechnology Co., Ltd. Corporation Information
6.14.2 Foshan Zhengdian Biotechnology Co., Ltd. Albendazole Veterinary Drug Description and Business Overview
6.14.3 Foshan Zhengdian Biotechnology Co., Ltd. Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Foshan Zhengdian Biotechnology Co., Ltd. Albendazole Veterinary Drug Product Portfolio
6.14.5 Foshan Zhengdian Biotechnology Co., Ltd. Recent Developments/Updates
6.15 Shanghai Shenya
6.15.1 Shanghai Shenya Corporation Information
6.15.2 Shanghai Shenya Albendazole Veterinary Drug Description and Business Overview
6.15.3 Shanghai Shenya Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Shanghai Shenya Albendazole Veterinary Drug Product Portfolio
6.15.5 Shanghai Shenya Recent Developments/Updates
6.16 Tianjin Bijia Pharmaceutical Co., Ltd.
6.16.1 Tianjin Bijia Pharmaceutical Co., Ltd. Corporation Information
6.16.2 Tianjin Bijia Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Description and Business Overview
6.16.3 Tianjin Bijia Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Tianjin Bijia Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Product Portfolio
6.16.5 Tianjin Bijia Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province
6.17.1 Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Corporation Information
6.17.2 Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Albendazole Veterinary Drug Description and Business Overview
6.17.3 Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Albendazole Veterinary Drug Product Portfolio
6.17.5 Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Recent Developments/Updates
6.18 Shimu Group
6.18.1 Shimu Group Corporation Information
6.18.2 Shimu Group Albendazole Veterinary Drug Description and Business Overview
6.18.3 Shimu Group Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Shimu Group Albendazole Veterinary Drug Product Portfolio
6.18.5 Shimu Group Recent Developments/Updates
6.19 CSTP
6.19.1 CSTP Corporation Information
6.19.2 CSTP Albendazole Veterinary Drug Description and Business Overview
6.19.3 CSTP Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.19.4 CSTP Albendazole Veterinary Drug Product Portfolio
6.19.5 CSTP Recent Developments/Updates
6.20 Sneha Medicare
6.20.1 Sneha Medicare Corporation Information
6.20.2 Sneha Medicare Albendazole Veterinary Drug Description and Business Overview
6.20.3 Sneha Medicare Albendazole Veterinary Drug Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Sneha Medicare Albendazole Veterinary Drug Product Portfolio
6.20.5 Sneha Medicare Recent Developments/Updates
7 Albendazole Veterinary Drug Manufacturing Cost Analysis
7.1 Albendazole Veterinary Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Albendazole Veterinary Drug
7.4 Albendazole Veterinary Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Albendazole Veterinary Drug Distributors List
8.3 Albendazole Veterinary Drug Customers
9 Albendazole Veterinary Drug Market Dynamics
9.1 Albendazole Veterinary Drug Industry Trends
9.2 Albendazole Veterinary Drug Market Drivers
9.3 Albendazole Veterinary Drug Market Challenges
9.4 Albendazole Veterinary Drug Market Restraints
10 Global Market Forecast
10.1 Albendazole Veterinary Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Albendazole Veterinary Drug by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Albendazole Veterinary Drug by Type (2023-2028)
10.2 Albendazole Veterinary Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Albendazole Veterinary Drug by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Albendazole Veterinary Drug by Application (2023-2028)
10.3 Albendazole Veterinary Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Albendazole Veterinary Drug by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Albendazole Veterinary Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Albendazole Veterinary Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Albendazole Veterinary Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Albendazole Veterinary Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Albendazole Veterinary Drug Market Competitive Situation by Manufacturers in 2021
Table 5. Global Albendazole Veterinary Drug Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Albendazole Veterinary Drug Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Albendazole Veterinary Drug Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Albendazole Veterinary Drug Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Albendazole Veterinary Drug Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Albendazole Veterinary Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Albendazole Veterinary Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Albendazole Veterinary Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Albendazole Veterinary Drug as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Albendazole Veterinary Drug Sales by Region (2017-2022) & (K Units)
Table 16. Global Albendazole Veterinary Drug Sales Market Share by Region (2017-2022)
Table 17. Global Albendazole Veterinary Drug Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Albendazole Veterinary Drug Revenue Market Share by Region (2017-2022)
Table 19. North America Albendazole Veterinary Drug Sales by Country (2017-2022) & (K Units)
Table 20. North America Albendazole Veterinary Drug Sales Market Share by Country (2017-2022)
Table 21. North America Albendazole Veterinary Drug Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Albendazole Veterinary Drug Revenue Market Share by Country (2017-2022)
Table 23. Europe Albendazole Veterinary Drug Sales by Country (2017-2022) & (K Units)
Table 24. Europe Albendazole Veterinary Drug Sales Market Share by Country (2017-2022)
Table 25. Europe Albendazole Veterinary Drug Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Albendazole Veterinary Drug Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Albendazole Veterinary Drug Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Albendazole Veterinary Drug Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Albendazole Veterinary Drug Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Albendazole Veterinary Drug Revenue Market Share by Region (2017-2022)
Table 31. Latin America Albendazole Veterinary Drug Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Albendazole Veterinary Drug Sales Market Share by Country (2017-2022)
Table 33. Latin America Albendazole Veterinary Drug Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Albendazole Veterinary Drug Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Albendazole Veterinary Drug Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Albendazole Veterinary Drug Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Albendazole Veterinary Drug Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Albendazole Veterinary Drug Revenue Market Share by Country (2017-2022)
Table 39. Global Albendazole Veterinary Drug Sales by Type (2017-2022) & (K Units)
Table 40. Global Albendazole Veterinary Drug Sales Market Share by Type (2017-2022)
Table 41. Global Albendazole Veterinary Drug Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Albendazole Veterinary Drug Revenue Share by Type (2017-2022)
Table 43. Global Albendazole Veterinary Drug Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Albendazole Veterinary Drug Sales (K Units) by Application (2017-2022)
Table 45. Global Albendazole Veterinary Drug Sales Market Share by Application (2017-2022)
Table 46. Global Albendazole Veterinary Drug Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Albendazole Veterinary Drug Revenue Share by Application (2017-2022)
Table 48. Global Albendazole Veterinary Drug Price by Application (2017-2022) & (US$/Unit)
Table 49. GSK Corporation Information
Table 50. GSK Description and Business Overview
Table 51. GSK Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. GSK Albendazole Veterinary Drug Product
Table 53. GSK Recent Developments/Updates
Table 54. Sequent Scientific Corporation Information
Table 55. Sequent Scientific Description and Business Overview
Table 56. Sequent Scientific Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Sequent Scientific Albendazole Veterinary Drug Product
Table 58. Sequent Scientific Recent Developments/Updates
Table 59. Zoetis Corporation Information
Table 60. Zoetis Description and Business Overview
Table 61. Zoetis Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Zoetis Albendazole Veterinary Drug Product
Table 63. Zoetis Recent Developments/Updates
Table 64. AdvaCare Pharma Corporation Information
Table 65. AdvaCare Pharma Description and Business Overview
Table 66. AdvaCare Pharma Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. AdvaCare Pharma Albendazole Veterinary Drug Product
Table 68. AdvaCare Pharma Recent Developments/Updates
Table 69. Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Corporation Information
Table 70. Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Description and Business Overview
Table 71. Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Product
Table 73. Guangdong Tianbao Biological Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 74. Hanzhonghe Times Biotechnology Co., Ltd. Corporation Information
Table 75. Hanzhonghe Times Biotechnology Co., Ltd. Description and Business Overview
Table 76. Hanzhonghe Times Biotechnology Co., Ltd. Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Hanzhonghe Times Biotechnology Co., Ltd. Albendazole Veterinary Drug Product
Table 78. Hanzhonghe Times Biotechnology Co., Ltd. Recent Developments/Updates
Table 79. Yahui Medicine Corporation Information
Table 80. Yahui Medicine Description and Business Overview
Table 81. Yahui Medicine Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Yahui Medicine Albendazole Veterinary Drug Product
Table 83. Yahui Medicine Recent Developments/Updates
Table 84. Beijing Shengmu Biotechnology Co., Ltd. Corporation Information
Table 85. Beijing Shengmu Biotechnology Co., Ltd. Description and Business Overview
Table 86. Beijing Shengmu Biotechnology Co., Ltd. Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Beijing Shengmu Biotechnology Co., Ltd. Albendazole Veterinary Drug Product
Table 88. Beijing Shengmu Biotechnology Co., Ltd. Recent Developments/Updates
Table 89. Hebei Huabang Biological Technology Co., Ltd. Corporation Information
Table 90. Hebei Huabang Biological Technology Co., Ltd. Description and Business Overview
Table 91. Hebei Huabang Biological Technology Co., Ltd. Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Hebei Huabang Biological Technology Co., Ltd. Albendazole Veterinary Drug Product
Table 93. Hebei Huabang Biological Technology Co., Ltd. Recent Developments/Updates
Table 94. Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Corporation Information
Table 95. Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Description and Business Overview
Table 96. Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Product
Table 98. Dongguan Meidehao Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 99. Sichuan Jinfeng Technology Corporation Information
Table 100. Sichuan Jinfeng Technology Description and Business Overview
Table 101. Sichuan Jinfeng Technology Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Sichuan Jinfeng Technology Albendazole Veterinary Drug Product
Table 103. Sichuan Jinfeng Technology Recent Developments/Updates
Table 104. Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Corporation Information
Table 105. Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Description and Business Overview
Table 106. Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Product
Table 108. Shijiazhuang Jinding Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 109. Anhui Shenhui Agricultural Technology Co., Ltd. Corporation Information
Table 110. Anhui Shenhui Agricultural Technology Co., Ltd. Description and Business Overview
Table 111. Anhui Shenhui Agricultural Technology Co., Ltd. Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Anhui Shenhui Agricultural Technology Co., Ltd. Albendazole Veterinary Drug Product
Table 113. Anhui Shenhui Agricultural Technology Co., Ltd. Recent Developments/Updates
Table 114. Foshan Zhengdian Biotechnology Co., Ltd. Corporation Information
Table 115. Foshan Zhengdian Biotechnology Co., Ltd. Description and Business Overview
Table 116. Foshan Zhengdian Biotechnology Co., Ltd. Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Foshan Zhengdian Biotechnology Co., Ltd. Albendazole Veterinary Drug Product
Table 118. Foshan Zhengdian Biotechnology Co., Ltd. Recent Developments/Updates
Table 119. Shanghai Shenya Corporation Information
Table 120. Shanghai Shenya Description and Business Overview
Table 121. Shanghai Shenya Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Shanghai Shenya Albendazole Veterinary Drug Product
Table 123. Shanghai Shenya Recent Developments/Updates
Table 124. Tianjin Bijia Pharmaceutical Co., Ltd. Corporation Information
Table 125. Tianjin Bijia Pharmaceutical Co., Ltd. Description and Business Overview
Table 126. Tianjin Bijia Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Tianjin Bijia Pharmaceutical Co., Ltd. Albendazole Veterinary Drug Product
Table 128. Tianjin Bijia Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 129. Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Corporation Information
Table 130. Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Description and Business Overview
Table 131. Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Albendazole Veterinary Drug Product
Table 133. Tianyuan Animal Medicine, Hanzhong City, Shaanxi Province Recent Developments/Updates
Table 134. Shimu Group Corporation Information
Table 135. Shimu Group Description and Business Overview
Table 136. Shimu Group Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Shimu Group Albendazole Veterinary Drug Product
Table 138. Shimu Group Recent Developments/Updates
Table 139. CSTP Corporation Information
Table 140. CSTP Description and Business Overview
Table 141. CSTP Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. CSTP Albendazole Veterinary Drug Product
Table 143. CSTP Recent Developments/Updates
Table 144. Sneha Medicare Corporation Information
Table 145. Sneha Medicare Description and Business Overview
Table 146. Sneha Medicare Albendazole Veterinary Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Sneha Medicare Albendazole Veterinary Drug Product
Table 148. Sneha Medicare Recent Developments/Updates
Table 149. Production Base and Market Concentration Rate of Raw Material
Table 150. Key Suppliers of Raw Materials
Table 151. Albendazole Veterinary Drug Distributors List
Table 152. Albendazole Veterinary Drug Customers List
Table 153. Albendazole Veterinary Drug Market Trends
Table 154. Albendazole Veterinary Drug Market Drivers
Table 155. Albendazole Veterinary Drug Market Challenges
Table 156. Albendazole Veterinary Drug Market Restraints
Table 157. Global Albendazole Veterinary Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 158. Global Albendazole Veterinary Drug Sales Market Share Forecast by Type (2023-2028)
Table 159. Global Albendazole Veterinary Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 160. Global Albendazole Veterinary Drug Revenue Market Share Forecast by Type (2023-2028)
Table 161. Global Albendazole Veterinary Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 162. Global Albendazole Veterinary Drug Sales Market Share Forecast by Application (2023-2028)
Table 163. Global Albendazole Veterinary Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 164. Global Albendazole Veterinary Drug Revenue Market Share Forecast by Application (2023-2028)
Table 165. Global Albendazole Veterinary Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 166. Global Albendazole Veterinary Drug Sales Market Share Forecast by Region (2023-2028)
Table 167. Global Albendazole Veterinary Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 168. Global Albendazole Veterinary Drug Revenue Market Share Forecast by Region (2023-2028)
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Albendazole Veterinary Drug
Figure 2. Global Albendazole Veterinary Drug Market Share by Type in 2021 & 2028
Figure 3. Capsule Product Product Picture
Figure 4. Table Product Product Picture
Figure 5. Global Albendazole Veterinary Drug Market Share by Application in 2021 & 2028
Figure 6. Swine
Figure 7. Cattle
Figure 8. Others
Figure 9. Global Albendazole Veterinary Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Albendazole Veterinary Drug Market Size (2017-2028) & (US$ Million)
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs